Nisa Investment Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.2K | Hold |
|
|||||
|
2025
Q2 | $6.43K | Sell |
|
|||||
|
2025
Q1 | $9.15K | Buy |
|
|||||
|
2024
Q4 | $3.08K | Sell |
|
|||||
|
2024
Q3 | $29.3K | Sell |
|
|||||
|
2024
Q2 | $37.4K | Buy |
|
|||||
|
2024
Q1 | $49.4K | Hold |
|
|||||
|
2023
Q4 | $26.6K | Buy |
|
|||||
|
2023
Q3 | $6.1K | Buy |
|
|||||
|
2023
Q2 | $10.9K | Buy |
|
|||||
|
2023
Q1 | $7K | Sell |
|
|||||
|
2022
Q4 | $43K | Sell |
|
|||||
|
2022
Q3 | $42K | Sell |
|
|||||
|
2022
Q2 | $57K | Buy |
|
|||||
|
2022
Q1 | $33K | Sell |
|
|||||
|
2021
Q4 | $91K | Sell |
|
|||||
|
2021
Q3 | $251 | Sell |
|
|||||
|
2021
Q2 | $283 | Hold |
|
|||||
|
2021
Q1 | $317 | Hold |
|
|||||
|
2020
Q4 | $271K | Buy |
|
|||||
|
2020
Q3 | $168K | Buy |
|
|||||
|
2020
Q2 | $32K | Buy |
|
|||||
|
2020
Q1 | $7K | Buy |
|
|||||
|
2019
Q4 | $6K | Hold |
|
|||||
|
2019
Q3 | $5K | Hold |
|
|||||
|
2019
Q2 | $8K | Hold |
|
|||||
|
2019
Q1 | $9K | Hold |
|
|||||
|
2018
Q4 | $6K | Hold |
|
|||||
|
2018
Q3 | $8K | Buy |
|